(Q40302309)

English

Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant.

scientific article published on 15 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

based on heuristic

inferred from title

Jaime Henrique Amorim

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Mariana Oliveira Diniz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Francisco A M O Cariri

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Juliana Falcão Rodrigues

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Raíza Sales Pereira Bizerra

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Antônio J S Gonçalves

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ada Maria de Barcelos Alves

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Luís Carlos de Souza Ferreira

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

0 references

publication date

15 December 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

837-845

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22178517%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dengue: a continuing global threat

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Prospects for a dengue virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Development of a live attenuated dengue virus vaccine using reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Dengue: defining protective versus pathologic immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Autoimmune pathogenesis in dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Monoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

The path to a successful vaccine adjuvant--'the long and winding road'.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Vaccine adjuvants: putting innate immunity to work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Experimental studies on dengue. I. Isolation, identification and modification of the virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Functional diversity of heat-labile toxins (LT) produced by enterotoxigenic Escherichia coli: differential enzymatic and immunological activities of LT1 (hLT) AND LT4 (pLT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Vectors to express foreign genes and techniques to monitor gene expression in Pseudomonads

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Endotoxin removal from protein solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Cutting edge: rapid in vivo killing by memory CD8 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Adjuvant requirement for successful immunization with recombinant derivatives of Plasmodium vivax merozoite surface protein-1 delivered via the intranasal route.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Regulation of interferon-gamma during innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Immunoaffinity purification of native dimer forms of the flavivirus non-structural glycoprotein, NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

Impact of dengue/dengue hemorrhagic fever on the developing world

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40302309&oldid=1488331440"